S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story

The Cutaneous Connection - En podcast af The Cutaneous Connection

Bradley Burnam, the founder and CEO of Turn Therapeutics, discusses his journey in the pharmaceutical landscape: from his battle with an aggressive antimicrobial resistant infection to the beginnings of Turn, and to the current state of Hexagen technology and its potential in eczema, onychomycosis, and more.

Visit the podcast's native language site